Omicron advancing rapidly in the Netherlands Infections involving the Omicron variant are still in the minority for now, but are increasing rapidly.
Vaccine-induced protection against an infection with the Delta variant of the coronavirus Vaccination offers more than 80% protection against an infection with the coronavirus SARS-CoV-2 among people under 70 years old who are tested due to symptoms.
The Netherlands almost meets EU air quality limit values in 2020 For the first time since the start of the NSL (2009), the Netherlands complies with the European limit values for nitrogen dioxide along traffic roads. The Netherlands almost met the limit values for particulate matter (PM10) in 2020.
Impact of ventilation on aerogenic transmission of the coronavirus RIVM has calculated the impact of different ventilation rates on the number of people who become ill due to aerogenic transmission of the coronavirus SARS-CoV-2 in indoor spaces.
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.
Significant increase in support for and compliance with coronavirus measures Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms increased during the recent period of high infection rates and hospital admissions.
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Healthcare utilisation increases with Long COVID symptoms More than 15,000 people are taking part in the LongCOVID study conducted by RIVM. Participants with existing long-term symptoms after COVID-19 (Long COVID) reported higher healthcare utilisation.